ArticleCancer biology & therapy2025

Potential therapeutic GSK-3β inhibitor 9-ING-41 is active in combination with venetoclax in double-hit lymphoma (DHL).

Haohao Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.